Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Prevalence evolution of Sars-CoV-2 infection in the city of São Paulo, 2020–2021

Bibliographic Data

ID16780468
AuthorsJosé Olímpio Moura De Albuquerque (0000-0002-5664-1283, Secretaria Municipal de Saúde), Gabriela Akemi Kamioka (0000-0002-2714-8473, Universidade de São Paulo), Geraldine Madalosso (0000-0001-9501-6205, Secretaria Municipal de Saúde), Sâmara Araújo Costa (0000-0002-2528-8018, Secretaria Municipal de Saúde), Paloma Bessa Ferreira (0000-0001-7200-0374, Secretaria Municipal de Saúde), Francisco Alberto Pino (0000-0002-7980-7573, Secretaria de Agricultura e Abastecimento), Ana Paula Sayuri Sato (0000-0001-8601-5884, Universidade de São Paulo), Ana Cláudia Alves De Carvalho (0000-0003-0969-8110, Secretaria Municipal de Saúde), Ana Beatriz Pagliaro Amorim (0000-0002-1042-0661, Secretaria Municipal de Saúde), Caroline Cotrim Aires (0000-0001-7121-8515, Secretaria Municipal de Saúde), Ana Paula Arruda Geraldes Kataoka (0000-0001-9149-2722, Secretaria Municipal de Saúde), Elisa San Martin Mouriz Savani (0000-0002-2380-6002, Secretaria Municipal de Saúde), Thirsa Álvares Franco Bessa (0000-0003-1676-2360, Secretaria Municipal de Saúde), Breno Souza De Aguiar (0000-0002-6621-228X, Secretaria Municipal de Saúde), Marcelo Antunes Failla (0000-0002-9004-7309, Secretaria Municipal de Saúde), Edson Aparecido dos Santos (0000-0003-1577-4300, Secretaria Municipal de Saúde), Edjane Maria Torreão Brito (0000-0002-6621-9430, Secretaria Municipal de Saúde), Maria Cristina Honório dos Santos (0000-0002-4526-4996, Secretaria Municipal de Saúde), Solange Maria Saboia e Silva (0000-0001-5626-3326, Secretaria Municipal de Saúde), Luiz Artur Vieira Caldeira (0000-0002-4326-1265, Secretaria Municipal de Saúde), Luiz Carlos Zamarco (0000-0003-0179-567X, Secretaria Municipal de Saúde), Sandra Maria Sabino Fonseca (0000-0002-7297-4678, Secretaria Municipal de Saúde), Marcia Maria de Cerqueira Lima (0000-0001-7416-4444, Secretaria Municipal de Saúde), Isabel A Marques (0000-0003-3841-1174, Secretaria Municipal de Saúde), Fabiana Érica Vilanova da Silva (0000-0001-5201-2693, Secretaria Municipal de Saúde), Paula Regina Glasser (0000-0001-9019-9137, Secretaria Municipal de Saúde), Patrícia Carla Piragibe Ramos Burihan (0000-0001-8005-5682, Secretaria Municipal de Saúde), Cinthya Luzia Cavazzana (0000-0002-5088-4831, Secretaria Municipal de Saúde), Débora Silva De Mello (0000-0001-7295-4709, Secretaria Municipal de Saúde), Alessandra Cristina Guedes Pellini (0000-0002-3799-9415, Universidade Nove de Julho), Fernando Yoshiki Nishio (0000-0003-2165-4647, Secretaria Municipal de Saúde), Fernanda Miyashiro Kian (0000-0001-8551-805X, Secretaria Municipal de Saúde), Elza de Santana Braga (0000-0001-9696-7037, Secretaria Municipal de Saúde), Nilza Maria Piassi Bertelli (0000-0003-4712-9381, Secretaria Municipal de Saúde), Wagner Fracini (0000-0003-1608-2373, Secretaria Municipal de Saúde), Marcelo Dell Áquila Gonçalves (0000-0003-0937-4677, Secretaria Municipal de Saúde), Paulete Secco Zular (0000-0002-1584-3057, Secretaria Municipal de Saúde), Regiane de Santana Piva (0000-0002-2709-7485, Secretaria Municipal de Saúde), Edoarda Masi (0000-0002-3315-364X, Secretaria Municipal de Saúde)
Year2021
Volume55
Pages62
Publication date2021-10-22
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueRevista de Saúde Pública (JOURNAL)
Journal identifiersISSN: 0034-8910 • E-ISSN: 0034-8910
PublisherUniversidade de São Paulo. Agência de Bibliotecas e Coleções Digitais (PUBLISHER)
DOI10.11606/s1518-8787.2021055003970
PMID34706038
OpenAlexW3208230890
LanguageEN
Citations received3
References cited4

OBJECTIVE To estimate the evolution of the prevalence of SARS-CoV-2 virus infection among residents aged 18 years or over in the municipality of São Paulo. METHODS This is a population-based household survey conducted every 15 days, between June and September 2020, and January and February 2021. In total, the study comprised 11 phases. The presence of antibodies against SARS-CoV-2 was identified in venous blood using a lateral flow test, Wondfo Biotech. In the last phase, the researchers combined it with an immunoenzymatic test, Euroimmun. The participants also answered a semi-structured questionnaire on sociodemographic and economic factors, and on social distancing measures. Prevalence estimates and the 95% confidence interval were estimated according to regions, Human Development Index, sex, age group, ethnicity, education, income, and variables associated with risk or prevention of infection. To compare the frequencies among the categories of each variable, the chi-square test with Rao-Scott correction was used, considering a significance level of 5%. RESULTS In total, 23,397 individuals were interviewed and had their samples collected. The estimated prevalence of antibodies against SARS-CoV-2 ranged from 9.7% (95%CI: 7.9–11.8%) to 25.0% (95%CI: 21.7–28.7). The prevalence of individuals with antibodies against the virus was higher among black and brown people, people with lower schooling and income, and among residents of regions with lower Human Development Index. The lowest prevalences were associated with recommended measures of disease protection. The proportion of asymptomatic infection was 45.1%. CONCLUSION The estimated prevalence of the infection was lower than the cumulative incidence variation, except for the last phase of the study. The differences in prevalence estimates observed among subpopulations showed social inequality as a risk of infection. The lower prevalence observed among those who could follow prevention measures reinforce the need to maintain social distancing measures as a way to prevent SARS-CoV-2 infection

Asymptomatic · Confidence interval · Coronavirus disease 2019 (COVID-19) · Disease · Environmental health · Ethnic group · Infectious disease (medical specialty) · Population · Social distance · COVID-19 epidemiological studies · Demography · Internal Medicine · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Gerontology

  • Soroprevalência de anticorpos do vírus Sars-CoV-2 em escolares no município de São Paulo, 2020

    Open Access•Gabriela Akemi Kamioka, Geraldine Madalosso et al.•Revista de Saúde Pública•2023

  • Prevalence evolution of Sars-CoV-2 infection in the city of São Paulo, 2020–2021

    Open Access•José Olímpio Moura De Albuquerque, Gabriela Akemi Kamioka et al.•Revista de Saúde Pública•2021

  • Seroepidemiology of Sars-CoV-2 on a partially vaccinated island in Brazil

    Open Access•José Cerbino-Neto, Igor Tona Peres et al.•Frontiers in Public Health•2022

  • Prevalence of Sars-CoV-2 in Spain (ENE-Covid)

    Open Access•M Pollán, Beatriz Pérez-Gómez et al.•The Lancet•2020

  • Sars-CoV-2 antibody prevalence in Brazil

    Open Access•Bernardo L Horta, Pedro C Hallal et al.•The Lancet Global Health•2020

  • Population-based seroprevalence of Sars-CoV-2 and the herd immunity threshold in Maranhão

    Open Access•Antonio Augusto Moura Da Silva, Lídio Gonçalves Lima Neto et al.•Revista de Saúde Pública•2020

  • Prevalence evolution of Sars-CoV-2 infection in the city of São Paulo, 2020–2021

    Open Access•José Olímpio Moura De Albuquerque, Gabriela Akemi Kamioka et al.•Revista de Saúde Pública•2021

Unique citing works3
Citations per year0,6
Citation span2021 - 2023 (3)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 1
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae